Chinook Therapeutics Inc Cvr (ADRO)
EBITDA Margin
-221.85%
TTM · Period ending:
ADRO EBITDA Margin
Latest reported-221.85%period ending
Latest reported-221.85%period ending
ADRO EBITDA Margin (-1923.31% → -221.85%)
Annual ebitda margin
High-resolution chart · PNG
ADRO ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -463.0954% | |
| -604.4078% | |
| -575.683% | |
| -132.4599% | |
| -52.8714% | |
| -107.3941% | |
| -1,923.3092% |